205 related articles for article (PubMed ID: 21439325)
1. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.
Pirrone V; Wigdahl B; Krebs FC
Antiviral Res; 2011 Jun; 90(3):168-82. PubMed ID: 21439325
[TBL] [Abstract][Full Text] [Related]
2. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
[TBL] [Abstract][Full Text] [Related]
4. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
5. Prospects of HIV-1 entry inhibitors as novel therapeutics.
Pierson TC; Doms RW; Pöhlmann S
Rev Med Virol; 2004; 14(4):255-70. PubMed ID: 15248253
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
7. Microbicides for multidrug-resistant and multitropic HIV-1.
D'Cruz OJ; Uckun FM
Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
[TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Uckun FM
Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
[TBL] [Abstract][Full Text] [Related]
10. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
11. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.
Rusnati M; Vicenzi E; Donalisio M; Oreste P; Landolfo S; Lembo D
Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134
[TBL] [Abstract][Full Text] [Related]
12. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Ketas TJ; Schader SM; Zurita J; Teo E; Polonis V; Lu M; Klasse PJ; Moore JP
Virology; 2007 Aug; 364(2):431-40. PubMed ID: 17428517
[TBL] [Abstract][Full Text] [Related]
13. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
D'Cruz OJ; Uckun FM
J Antimicrob Chemother; 2006 Mar; 57(3):411-23. PubMed ID: 16431862
[TBL] [Abstract][Full Text] [Related]
14. Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission.
Pacciarini F; Ghezzi S; Pinna D; Cima S; Zoppetti G; Oreste P; Poli G; Vicenzi E
New Microbiol; 2004 Apr; 27(2 Suppl 1):5-9. PubMed ID: 15646059
[TBL] [Abstract][Full Text] [Related]
15. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
Fletcher PS; Shattock RJ
Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
Kadow J; Wang HG; Lin PF
Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
[TBL] [Abstract][Full Text] [Related]
18. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
[TBL] [Abstract][Full Text] [Related]
19. A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]).
D'Cruz OJ; Qazi S; Yiv S; Uckun FM
Expert Opin Investig Drugs; 2012 Mar; 21(3):265-79. PubMed ID: 22292483
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
